LDNscience® is a public information project of the MedInsight® Research Institute, which is a U.S./U.K. based non-profit organization established in 2006. MedInsight® serves as a platform for researching and indexing available off-label (repurposed) treatments for cancer and chronic diseases.
Our People
Our Founder
Moshe Rogosnitzky
Research Scientist, Innovator and Inventor
Our Team Members
We thank the generous sponsors who keep LDNscience® going.
Visit our CureLeaders® Board where you can see our generous supporters.
Gold
Louise Andreas
LDN has saved my life! Thank you!
Diamond
Nicole Solomon
Big LDN fan - Good luck!!
Bronze
Wendy Lowe
Bronze
Peter Bauman
Proud to support LDNscience! Keep up the good work!
Revamped LDN site launched -- biggest patient-initiated drug discovery program in history
MedInsight® Announces Clinical Trial Results of Low-dose Naltrexone; Potential Breakthrough For Crohn's Disease Patients
LDNscience® Media Release - New Website Aims to Clear Up Misconceptions About Breakthrough Drug Low Dose Naltrexone (LDN)
Dipyridamole Eye Drops
Cureiosity®